18th Meeting of the EAU Section of Oncological Urology
For the 18th edition of this cutting-edge meeting, the organising committee has prepared a programme that reflects the state of the art of oncology in urology and places the ESOU meeting as a European reference in the field.
2020 has been a very tough year for every one of us as European citizens and as primary care providers and physicians. The COVID-19 outbreak has traumatised our countries, our societies, our healthcare systems, and our patients diagnosed and treated for cancer. The European Association of Urology has promoted guidelines during the crisis to help urologists treat these patients and prevent suboptimal care. Despite the severity of the COVID-19 outbreak, cancer is still taking more lives than this coronavirus. Now is the time to be there for our patients even more and address their concerns. Thus, there will be a plenty to say in the upcoming edition of ESOU21 in Sweden.
ESOU21 is also an opportunity to meet colleagues in person after almost a year of virtual meetings. This is already a good reason and a good motivation to gather in Gothenburg. All attendees will have the chance to take part in lively provocative discussions at the meeting; and receive key updates of the best and latest research and techniques, on top of valuable insights from Europe’s leading opinion leaders. At this meeting, we will also emphasise our renewed partnership with the SUO (Society of Urological Oncology) with a special lecture.
ESOU21 will also take place in conjunction with the meeting of the EAU Section of Urological Research (ESUR). Thus it will be an opportunity to have collaborative sessions and knowledge exchange with our colleagues from this prestigious office of the EAU.
Lastly, we will certainly address the impact and repercussions of COVID-19 on the management of onco-urology patients. We will exchange insights on prioritization for surgical healthcare access in the OR.
At ESOU21, we will also recognise the best article published in the European Urology Oncology journal, and put forward the young generation by giving the former winners of the STEPS Programme the opportunity to give their presentations.
We look forward to meeting you in Sweden at #ESOU21!
|Prof. Morgan Rouprêt
Share ESOU21 with your friends and colleagues:
Cumulation of vital onco-urological data
ESOU21 will deliver essential and potentially practice-changing data from new trials and indications.
The programme is enriched with contributions from the ESUR and ESUP sections, and associations such as the SUO and ASCO.
Welcoming the new generation
ESOU21 will acknowledge young and promising talent through the STEPS programme and an award recognition.